Acetylcholine receptor binding antibody–associated myasthenia gravis, myocarditis, and rhabdomyolysis induced by tislelizumab in a patient with colon cancer: A case report and literature review

Despite the intriguing therapeutic prospects offered by immune checkpoint inhibitors (ICIs), immune-related adverse events (irAEs) become an increasingly important safety issue. Herein, we report a patient with locally advanced colorectal cancer (LACRC) who received anti-programmed cell death protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shengnan, Peng, Danping, Zhu, Hao, Min, Wanwan, Xue, Mengru, Wu, Rui, Shao, Yanqing, Pan, Lin, Zhu, Mingqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773380/
https://www.ncbi.nlm.nih.gov/pubmed/36568231
http://dx.doi.org/10.3389/fonc.2022.1053370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773380/
https://www.ncbi.nlm.nih.gov/pubmed/36568231
http://dx.doi.org/10.3389/fonc.2022.1053370

Ejemplares similares